Drawing for REXULTI VORTIOXETINE

USPTO serial 79134109

REXULTI VORTIOXETINE

Reviewed by CopyMark Law Group

Reg. 4582247Status 404
Filing date
Status date
Registration date
Aug 12, 2014
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REXULTI VORTIOXETINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1155 Avenue of the AmericasPatent and Trademark DepartmentNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, psychosis, anxiety, insomnia, schizophrenia, bipolar disorder and disease, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposes; all the forgoing containing in whole or substantial part vortioxetineSECTION 70 - CANCELLED—
009Scientific apparatus and instruments, namely, magnetic, electronic and optical data carriers containing information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; pre-recorded audio cassettes, pre-recorded video cassettes, and electronic and digital media featuring information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; recorded computer software, namely, software for searching, storing, cataloging, and indexing medical and pharmaceutical information, indexing education and sales activities and for enabling web-based access to websites, enabling database integration, and enabling web searching of websites, intranet and Internet; data processing equipment and computers; software, namely, downloadable application software containing information on the use of pharmaceutical products and on diseases and disorders of the central nervous system and the treatment thereof; downloadable electronic game software which provide information related to diseases and disorders of the central nervous system and the treatment thereof, and downloadable mobile application software that allows transmitting, sharing, receiving, downloading, displaying and transferring content, text, visual works, audio works, audiovisual works, literary works, data, files, documents and electronic works via portable and handheld electronic devices and computers in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; application software for mobile devices, apparatus and medical instruments for controlling and managing patient medical information and interactionSECTION 70 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, examination systems consisting primarily of medical instruments for use in diagnosing central nervous system disorders; suture materials; apparatus and instruments for diagnostic purposes for diseases and disorders of the central nervous system; integrated medical systems consisting primarily of medical instruments for central nervous system and central nervous system related diagnostics, computer hardware and software for medical information and medical information management for use of a web-based physical and psychological examination and assessment of patients and information, guidance and control of medicinesSECTION 70 - CANCELLED—
041Education, namely, providing seminars, conferences, symposiums, workshops, courses, classes and lectures in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; providing of training in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; entertainment, namely, organizing, arranging, and conducting running, walking, golf, tennis, softball, and cycling events and cultural activities; arranging and conducting seminars, conferences, symposiums, workshops, and training courses in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; educational and training services in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders all provided electronically, on-line, via cable and Internet and other electronic media; providing nondownloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disordersSECTION 70 - CANCELLED—
042Scientific and technological services in the nature of scientific research, analysis, and testing and research and design relating thereto in the field of medicine; industrial research and analysis of diseases and disorders, treatments of diseases and disorders and prevention of diseases and disorders; design and development of computer hardware and software; providing software and access to data and information in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; pharmaceutical research and development; scientific and technological services in the nature of scientific research, analysis, and testing in the field of disorders, diseases and prevention; scientific and technological services in the nature of scientific research, analysis, and testing in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests; clinical research and tests; diagnostic research and tests; providing for medical and medicinal information related to medical diagnostics, medicine, pharmaceuticals, diseases, disorders, treatments of diseases and disorders, and prevention of diseases and disorders in the field of research and development, science, clinical testsSECTION 70 - CANCELLED—
044Medical services; services in the field of psychiatry and psychology; services and advice related to medical and pharmaceutical preparations and substances; medical clinical services; medical treatment services; therapeutic medical treatment services; healthcare and medical services related to central nervous system disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic medicine, medical dose, pharmaceuticals, disorders, diseases, treatments and prevention; all the aforementioned services provided off-line as well as on-line through a website featuring advice and information on the foregoingSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 31, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 13, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 27, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 27, 2015FIMPFINAL DISPOSITION PROCESSED—
Nov 12, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 12, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 12, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2014GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 7, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 7, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2014DMCCDATA MODIFICATION COMPLETED—
Apr 17, 2014PBPRWITHDRAWN FROM PUB - ESU SUPERVISOR REQUEST—
Apr 16, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 16, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 16, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Apr 16, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 16, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 16, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 8, 2014ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 5, 2014PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 27, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 24, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Mar 24, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 24, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 24, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2014ALIEASSIGNED TO LIE—
Feb 19, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2013RFNTREFUSAL PROCESSED BY IB—
Sep 4, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 4, 2013RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 20, 2013DOCKASSIGNED TO EXAMINER—
Aug 20, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 16, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 15, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance